dihexa hgf/c-met potentiator The Axis: A Promising Therapeutic Target in Cancer Dihexa 20mg Qty25 – NewBioRx
Dihexa 20mg Qty25 NewBioRx Activated HGF c Met Axis in Head and Neck Cancer DIHEXA HGF c Met pathway inhibition combined with chemotherapy increases cytotoxic T cell infiltration and inhibits pancreatic tumour growth and metastasis ScienceDirect
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27


